Expression of Different Proliferation Biomarkers in Adreno-cortical Tumors

NCT02747355 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2019-01-18

No results posted yet for this study

Summary

In adrenal tumors, the investigators will examine if there is any correlation between WIESS criteria, prognosis of the tumor, and the different labeling index of the following proliferation biomarkers: MCM3, MCM2, KI-67, P53, NEUROPILIN -1, METALLOTHIONEIN, SEMAPHORIN-3A.

Conditions

  • Adrenal Cortex Neoplasms
  • Adrenal Cortex Diseases

Sponsors & Collaborators

  • Bnai Zion Medical Center

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-18
Primary Completion
2018-07-01
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02747355 on ClinicalTrials.gov